Araim Pharmaceuticals’ Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

2020-08-17T21:05:02+00:00Biopharmaceutical Product Development, Industry News|

The double blind, randomized, placebo-controlled, two-center study published in Investigative Ophthalmology & Visual Science assessed the safety and efficacy of [...]

Chronic Severe Pain Defines Lives of Sarcoidosis Patients, According to Sarcoidosis/ FSR/ ARAIM Survey Results

2020-08-17T21:06:12+00:00Biopharmaceutical Product Development, Industry News|

A large proportion of sarcoidosis patients live with severe chronic pain despite the heavy use of painkillers, including opioids, a [...]

Go to Top